Hubei Jichuan Pharmaceutical Company has completed the cancellation of 171,800 stock options.

Hubei Jichuan Pharmaceuticals Co., Ltd. Announcement: According to the authorization of the second extraordinary general meeting of shareholders in 2022, the company convened the 17th meeting of the 10th Board of Directors on September 9, 2025, to review and approve the resolution to cancel certain stock options. Due to some incentive recipients leaving their positions and not meeting performance standards, the company plans to cancel 171,800 stock options that have been granted but not yet exercised. The company has submitted the cancellation application, which has been reviewed and confirmed by the Shanghai branch of China Securities Depository and Clearing Corporation Limited. The cancellation of these 171,800 stock options has been completed recently. This cancellation will not affect the company's share capital structure, nor will it affect the continued implementation of the incentive plan.